Health Canada Accepts Vertex's Suzetrigine New Drug Submission for Acute Pain
Health Canada accepted Vertex's New Drug Submission for suzetrigine, a selective NaV1.8 pain signal inhibitor for acute pain. The FDA-approved drug could become Canada's first new class of acute pain medicine in over 20 years.